CLARIVATE PLC (CLVT)

Sep 24, 2026

Clarivate Plc announced the completion and results of a cash tender offer by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for select debt securities. The details of the offer's expiration and outcome were disclosed in a Form 8-K filing with the SEC on September 24, 2026, with a press release providing specific terms and acceptance rates. Clarivate Plc's principal executive office is in London, UK, and its shares trade on the NYSE under the ticker CLVT.

Sep 22, 2026

Clarivate Plc announced that it will report its Third Quarter 2026 financial results on November 3, 2026. The announcement was made through PR Newswire. This brief notice serves to inform stakeholders of the upcoming earnings release.

Sep 17, 2026

Clarivate plc has named three key GLP-1 researchers among its 2026 Citation Laureates, recognizing the scientific breakthroughs behind these blockbuster peptide hormones. This acknowledgment comes as the treatment potential for GLP-1 drugs continues to expand beyond traditional metabolic indications. The article also mentions the inclusion of gene editing in the Citation Laureates list.

Sep 17, 2026

Clarivate Science Holdings Corporation, a wholly-owned subsidiary of Clarivate Plc, has launched a cash tender offer for specific debt securities. This announcement was made on September 17, 2026, via a Form 8-K filing with the SEC. While the filing confirms the tender offer, details regarding the financial terms, pricing, or deadlines are not provided within the main body of the document, instead referring to an attached press release (Exhibit 99.1).